The tariff classification of Pramipexole Dihydrochloride Extended Release Tablets in dosage form, from India
Reasoning
The tariff classification of Pramipexole Dihydrochloride Extended Release Tablets in dosage form, from India
Cite this ruling
CBP Ruling N303369 (3004909240): The tariff classification of Pramipexole Dihydrochloride Extended Release Tablets in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Bupropion Hydrochloride Extended Release Tablets, imported in dosage form, from India
The tariff classification of Metaxalone Tablets, imported in dosage form, from India
The tariff classification of Buspirone Hydrochloride Tablets, Pramipexole Dihydrochloride Extended Release Tablets, Minocycline Hydrochloride Extended Release Tablets, imported in dosage form, from India
The tariff classification of Buspirone Hydrochloride Tablets, Pramipexole Dihydrochloride Extended Release Tablets, Minocycline Hydrochloride Extended Release Tablets, imported in dosage form, from India
The tariff classification of Felodipine Tablets, imported in dosage form, from India Correction to Ruling Number N242513